BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22632751)

  • 1. Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer.
    García-Mauriño S; Alcaide A; Domínguez C
    Curr Pharm Des; 2012; 18(26):3853-73. PubMed ID: 22632751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer.
    Afzal O; Altamimi ASA; Mubeen B; Alzarea SI; Almalki WH; Al-Qahtani SD; Atiya EM; Al-Abbasi FA; Ali F; Ullah I; Nadeem MS; Kazmi I
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Links of Autophagy Dysfunction to Inflammatory Bowel Disease Onset.
    El-Khider F; McDonald C
    Dig Dis; 2016; 34(1-2):27-34. PubMed ID: 26982478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases.
    Retnakumar SV; Muller S
    Trends Mol Med; 2019 Jun; 25(6):516-537. PubMed ID: 30952481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autophagy in the pathogenesis of inflammatory bowel disease.
    Iida T; Onodera K; Nakase H
    World J Gastroenterol; 2017 Mar; 23(11):1944-1953. PubMed ID: 28373760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
    Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
    Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo.
    O'Donovan TR; Rajendran S; O'Reilly S; O'Sullivan GC; McKenna SL
    PLoS One; 2015; 10(8):e0134676. PubMed ID: 26248051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin.
    Lin YM; Chen CI; Hsiang YP; Hsu YC; Cheng KC; Chien PH; Pan HL; Lu CC; Chen YJ
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback autophagy activation as a key resistance factor of Ku-0060648 in colorectal cancer cells.
    Mao M; Liu Y; Gao X
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1244-1249. PubMed ID: 28676397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of miRNA and autophagy on colorectal cancer.
    Long J; He Q; Yin Y; Lei X; Li Z; Zhu W
    Cell Prolif; 2020 Oct; 53(10):e12900. PubMed ID: 32914514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin, autophagy and intestinal bowel disease.
    Talero E; Garcia-Maurino S; Motilva V
    Curr Pharm Des; 2014; 20(30):4816-27. PubMed ID: 24251670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MiRNAs in Inflammatory Bowel Disease.
    Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
    Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies.
    You L; Jin S; Zhu L; Qian W
    Oncotarget; 2017 Feb; 8(7):12374-12388. PubMed ID: 27902471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Huang Y; Zhou J; Luo S; Wang Y; He J; Luo P; Chen Z; Liu T; Tan X; Ou J; Miao H; Liang H; Shi C
    Gut; 2018 Feb; 67(2):307-319. PubMed ID: 27849558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
    Koustas E; Karamouzis MV; Mihailidou C; Schizas D; Papavassiliou AG
    Cancer Lett; 2017 Jun; 396():94-102. PubMed ID: 28323034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.
    Patel S; Hurez V; Nawrocki ST; Goros M; Michalek J; Sarantopoulos J; Curiel T; Mahalingam D
    Oncotarget; 2016 Sep; 7(37):59087-59097. PubMed ID: 27463016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-212 and mTOR form a regulation loop to modulate autophagy in colorectal adenoma HT-29 cells.
    Ji C; Ju S; Qiang J
    Discov Med; 2018 Jun; 25(140):265-275. PubMed ID: 30021100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer-a Critical Review.
    Szczepaniak A; Fichna J
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31443436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
    Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
    Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy and Inflammatory Diseases.
    Jin M; Zhang Y
    Adv Exp Med Biol; 2020; 1207():391-400. PubMed ID: 32671761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.